Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiosurgery for Newly Diagnosed Brain Metastases
NCT00582075Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2002
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in brain metastases, sponsored by University of Alabama at Birmingham. Primary endpoint: Percentage of Participants With Distant Brain Failure (DBF) at One Year at 1 year. Started Jul 2002; status: completed.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00582075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582075.